# Asian Diabetes Outcomes Prevention Trial

Study · id `cardio:ct-nct04286399` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04286399](<https://clinicaltrials.gov/study/NCT04286399>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04286399

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2400 participants.

## Technical summary

Registry record NCT04286399. Randomized; no masking; primary purpose treatment. Start 2019-07-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2400 participants (planned count; ClinicalTrials.gov record NCT04286399, source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)
- Started: 2019-07-01 (actual) (ClinicalTrials.gov record NCT04286399, source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)
- Primary completion: 2022-06-30 (anticipated) (ClinicalTrials.gov record NCT04286399, source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)
- Completion: 2034-06-30 (anticipated) (ClinicalTrials.gov record NCT04286399, source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT04286399, source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04286399-2021-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Asian Diabetes Outcomes Prevention Trial
- Acronym: ADOPT
- Condition: Diabetes Mellitus
- Condition: Cardiovascular Diseases
- Intervention (Drug): Renin-angiotensin-aldosterone system inhibitors
- Intervention (Drug): Beta blocker
- Intervention (Drug): SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor Product
- Lead sponsor: National Heart Centre Singapore
- Lead sponsor class: OTHER
- Collaborator: Singapore General Hospital
- Collaborator class: OTHER
- Collaborator: Mackay Memorial Hospital
- Collaborator class: OTHER
- Collaborator: National Taiwan University Hospital
- Collaborator class: OTHER
- Collaborator: Peking University People's Hospital
- Collaborator class: OTHER
- Collaborator: Medanta, The Medicity, India
- Collaborator class: OTHER
- Collaborator: Public Health Foundation of India
- Collaborator class: OTHER
- Collaborator: Putrajaya Hospital, Malaysia
- Collaborator class: UNKNOWN
- Collaborator: Universiti Teknologi Mara
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: National Heart Centre Singapore (`cardio:org-national-heart-centre-singapore`)
- Registry lists this organization as a collaborator: Singapore General Hospital (`cardio:org-singapore-general-hospital`)
- Registry lists this organization as a collaborator: Mackay Memorial Hospital (`cardio:org-mackay-memorial-hospital`)
- Registry lists this organization as a collaborator: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)
- Registry lists this organization as a collaborator: Peking University People's Hospital (`cardio:org-peking-university-people-s-hospital`)
- Registry lists this organization as a collaborator: Medanta, The Medicity, India (`cardio:org-medanta-the-medicity-india`)

## Provenance

Content hash: 7caaf55f70b365d133f68284f8a7a258f362d5af520e17bf7be5e715bd7d1d6b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
